Vimarsana
Biggest News Aggregation in the World

Optum Clinformatics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optum Clinformatics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optum Clinformatics Today - Breaking & Trending Today

Utilization of Antiviral Therapy for Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Nationwide Real-World US Study. - Vimarsana News

Utilization of Antiviral Therapy for Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Nationwide Real-World US Study.

Although oral antiviral therapy (OAV) is reported to improve outcomes in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), it is underutilized. We determined the rate and factors associated with OAV utilization among patients with HBV-related HCC in a US population with health insurance.Patients with HBV-related HCC were identified from the de-identified administrative health

Biosense Webster Study Links Lower Risk of Heart Failure in Atrial Fibrillation Patients Treated with Catheter Ablation Compared to Antiarrhythmic Drugs - Vimarsana News

Biosense Webster Study Links Lower Risk of Heart Failure in Atrial Fibrillation Patients Treated with Catheter Ablation Compared to Antiarrhythmic Drugs

Retrospective study of over 18,000 drug-refractory AFib patients found those treated with catheter ablation had a 57% lower risk of developing heart failure compared to those receiving antiarrhythmic drugs 

Biosense Webster study supports catheter ablation for AFib - Vimarsana News

Biosense Webster study supports catheter ablation for AFib

Johnson & Johnson's Biosense Webster today announced data supporting the use of catheter ablation in AFib patients.

Here's why overprescribing antibiotics can be harmful - Vimarsana News

Here's why overprescribing antibiotics can be harmful

Over prescription of antibiotics has led to antibiotic resistance and the emergence of bacteria like MRSA. A recent study by Intermountain Healthcare has found that one in 10 antibiotic prescriptions causes adverse events.

Source: upr.org
AKI hospitalization correlates with risk of death, rehospitalization - Vimarsana News

AKI hospitalization correlates with risk of death, rehospitalization

Patients who experience AKI during hospitalization showed an increased risk for 90- and 365-day all-cause and selected-cause rehospitalization and death following discharge, according to data in the American Journal of Kidney Diseases.“We hope this study leads to a growing awareness about the dramatic increased adverse risks after a hospitalization with AKI – outcomes that could

Source: healio.com